Mark Demario

Author PubWeight™ 3.60^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors.	J Clin Oncol	2012	2.04
2	RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response.	Clin Cancer Res	2013	0.84
3	Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays.	Methods	2012	0.79